{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:30:31Z","timestamp":1765355431557},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s11255-008-9510-0","type":"journal-article","created":{"date-parts":[[2009,1,5]],"date-time":"2009-01-05T19:29:13Z","timestamp":1231183753000},"page":"363-371","source":"Crossref","is-referenced-by-count":15,"title":["Beneficial effects of magnesium in chronic renal failure: a foe no longer"],"prefix":"10.1007","volume":"41","author":[{"given":"Ioannis P.","family":"Tzanakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios G.","family":"Oreopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"9510_CR1","first-page":"1213","volume-title":"Hypertension: pathophysiology, diagnosis and management","author":"BM Altura","year":"1995","unstructured":"Altura BM, Altura BT (1995) Role of magnesium in the pathogenesis of hypertension updated: relationship to its actions on cardiac, vascular smooth muscle and endothelial cells. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. Raven Press, New York, pp 1213\u20131242"},{"key":"9510_CR2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI115317","volume":"88","author":"KD Fine","year":"1991","unstructured":"Fine KD, Santa Ana CA, Porter JL, Fordtran JS (1991) Intestinal absorption of magnesium from food and supplements. J Clin Invest 88:396\u2013402. doi: 10.1172\/JCI115317","journal-title":"J Clin Invest"},{"issue":"1","key":"9510_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI113886","volume":"83","author":"MS Sheikh","year":"1989","unstructured":"Sheikh MS, Maguire JA, Emmett M, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS (1989) Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study. J Clin Invest 83(1):66\u201373. doi: 10.1172\/JCI113886","journal-title":"J Clin Invest"},{"issue":"84\u201386","key":"9510_CR4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(86)90987-6","volume":"1","author":"R O\u2019Donovan","year":"1986","unstructured":"O\u2019Donovan R, Baldwin D, Hammer M, Moniz C, Parsons V (1986) Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet 1(84\u201386):880\u2013882. doi: 10.1016\/S0140-6736(86)90987-6","journal-title":"Lancet"},{"issue":"4","key":"9510_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000187238","volume":"63","author":"V Parsons","year":"1993","unstructured":"Parsons V, Baldwin D, Moniz C, Marsden J, Ball E, Rifkin I (1993) Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders. Nephron 63(4):379\u2013383","journal-title":"Nephron"},{"issue":"2","key":"9510_CR6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000182446","volume":"30","author":"AP Guillot","year":"1982","unstructured":"Guillot AP, Hood VL, Runge CF, Gennari FJ (1982) The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis. Nephron 30(2):114\u2013117","journal-title":"Nephron"},{"issue":"2","key":"9510_CR7","first-page":"45","volume":"8","author":"H Roujouleh","year":"1987","unstructured":"Roujouleh H, Lavaud S, Toupance O, Melin JP, Chanard J (1987) Magnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload. Nephrologie 8(2):45\u201350","journal-title":"Nephrologie"},{"issue":"4","key":"9510_CR8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0272-6386(87)80021-5","volume":"10","author":"GM Shah","year":"1987","unstructured":"Shah GM, Winer RL, Cutler RE, Arieff AI, Goodman WG, Lacher JW et al (1987) Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 10(4):268\u2013275","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"9510_CR9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.ndt.a091722","volume":"3","author":"P Moriniere","year":"1988","unstructured":"Moriniere P, Vinatier I, Westeel PF, Cohemsolal M, Belbrik S, Abdulmassih Z et al (1988) Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uremic patients on chronic haemodialysis: lack of deleterious effect on bone mineralization. Nephrol Dial Transplant 3(5):651\u2013656","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"9510_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ki.1996.22","volume":"49","author":"JA Delmez","year":"1996","unstructured":"Delmez JA, Kelber J, Norword KY, Giles KS, Slatopolsky E (1996) Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study. Kidney Int 49(1):163\u2013167. doi: 10.1038\/ki.1996.22","journal-title":"Kidney Int"},{"key":"9510_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11255-007-9300-0","volume":"40","author":"I Tzanakis","year":"2008","unstructured":"Tzanakis I, Papadaki A, Wei M, Kagia S, Spadidakis V, Kallivretakis N, Oreopoulos DG (2008) Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Int Urol Nephrol 40:193\u2013201. doi: 10.1007\/s11255-007-9300-0","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"9510_CR12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.jrn.2007.08.005","volume":"17","author":"DM Spiegel","year":"2007","unstructured":"Spiegel DM, Farmer B, Smits G, Chonchol M (2007) Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. J Ren Nutr 17(6):416\u2013422. doi: 10.1053\/j.jrn.2007.08.005","journal-title":"J Ren Nutr"},{"key":"9510_CR13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1525-139X.2007.00306.x","volume":"20","author":"CW McIntyre","year":"2007","unstructured":"McIntyre CW (2007) New developments in the management of hyperphosphatemia in chronic kidney disease. Semin Dial 20:337\u2013341. doi: 10.1111\/j.1525-139X.2007.00306.x","journal-title":"Semin Dial"},{"key":"9510_CR14","unstructured":"Tumlin J, Toft, Ross C, Pai P, Roe S, McIntyre C, Chapman A (2008) MD879RP tablet, a novel anion exchange compound, for the effective treatment of hyperphosphatemia in patients with end-stage renal disease on haemodialysis. In: XLV EDTA-ERA congress, Stockholm, Sweden. May 10\u201313, 2008"},{"issue":"3\u20134","key":"9510_CR15","first-page":"182","volume":"5","author":"Y Rayssiguier","year":"1986","unstructured":"Rayssiguier Y (1986) Magnesium, lipids and vascular diseases. Experimental evidence in animal models. Magnesium 5(3\u20134):182\u2013190","journal-title":"Magnesium"},{"issue":"1\u20133","key":"9510_CR16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1385\/BTER:90:1-3:251","volume":"90","author":"H Cohen","year":"2002","unstructured":"Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R et al (2002) Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water. Biol Trace Elem Res 90(1\u20133):251\u2013259. doi: 10.1385\/BTER:90:1-3:251","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"9510_CR17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0753-3322(02)00343-8","volume":"57","author":"PO Schwille","year":"2003","unstructured":"Schwille PO, Schmiedl A, Schwille R, Brunner P, Kissler H, Cesnjevar R et al (2003) Media calcification, low erythrocyte magnesium, altered plasma magnesium, and calcium homeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat differential preventive effects of long-term oral magnesium supplementation alone and in combination with alkali. Biomed Pharmacother 57(2):88\u201397","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"9510_CR18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ki.1987.222","volume":"32","author":"HE Meema","year":"1987","unstructured":"Meema HE, Oreopoulos DG, Rapoport A (1987) Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32(3):388\u2013394. doi: 10.1038\/ki.1987.222","journal-title":"Kidney Int"},{"issue":"2","key":"9510_CR19","first-page":"162","volume":"15","author":"H Izawa","year":"1974","unstructured":"Izawa H, Imura M, Kuroda M, Takeda R (1974) Effect of magnesium on secondary hyperparathyroidism in chronic hemodialysis: a case with soft tissue calcification improved by high Mg dialysate. Calcif Tissue Res 15(2):162","journal-title":"Calcif Tissue Res"},{"issue":"9","key":"9510_CR20","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/ndt\/12.9.2036","volume":"12","author":"I Tzanakis","year":"1997","unstructured":"Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D et al (1997) Mitral annular calcification in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 12(9):2036\u20132037. doi: 10.1093\/ndt\/12.9.2035","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"9510_CR21","first-page":"102","volume":"17","author":"I Tzanakis","year":"2004","unstructured":"Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefyllakis N et al (2004) Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 17(2):102\u2013108","journal-title":"Magnes Res"},{"issue":"4","key":"9510_CR22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5414\/CNP68222","volume":"68","author":"E Ishimura","year":"2007","unstructured":"Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, Inaba M, Nishizawa Y (2007) Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 68(4):222\u2013227","journal-title":"Clin Nephrol"},{"key":"9510_CR23","unstructured":"Tzanakis I, Tsomi A, Mantakas E, Papadaki AN, Kalliretakis N (2006) The higher intracellular magnesium, the better long-term survival on hemodialysis. Paper presented at the 39th ASN congress, San Diego, CA, USA, 16\u201321 November 2006"},{"issue":"4","key":"9510_CR24","first-page":"237","volume":"20","author":"E Ishimura","year":"2007","unstructured":"Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y (2007) Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 20(4):237\u2013244","journal-title":"Magnes Res"},{"issue":"15","key":"9510_CR25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/ajhp\/61.15.1569","volume":"61","author":"JG Gums","year":"2004","unstructured":"Gums JG (2004) Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 61(15):1569\u20131576","journal-title":"Am J Health Syst Pharm"},{"key":"9510_CR26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0098-2997(02)00095-X","volume":"24","author":"J Maier","year":"2003","unstructured":"Maier J (2003) Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med 24:137\u2013146. doi: 10.1016\/S0098-2997(02)00095-X","journal-title":"Mol Aspects Med"},{"issue":"4","key":"9510_CR27","first-page":"275","volume":"18","author":"K Ueshima","year":"2005","unstructured":"Ueshima K (2005) Magnesium and ischemic heart disease: a review of epidemiological, experimental, and clinical evidences. Magnes Res 18(4):275\u2013284","journal-title":"Magnes Res"},{"key":"9510_CR28","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI108239","volume":"56","author":"RM Bennett","year":"1975","unstructured":"Bennett RM, Lehr JR, McCarty DJ (1975) Factors affecting the solubility of calcium pyrophosphate dehydrate crystals. J Clin Invest 56:1571\u20131579. doi: 10.1172\/JCI108239","journal-title":"J Clin Invest"},{"key":"9510_CR29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/ajkd.2001.27394","volume":"38","author":"CM Giachelli","year":"2001","unstructured":"Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H (2001) Vascular calcification and inorganic phosphate. Am J Kidney Dis 38:34\u201337. doi: 10.1053\/ajkd.2001.27394","journal-title":"Am J Kidney Dis"},{"key":"9510_CR30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11255-006-0082-6","volume":"38","author":"M Wei","year":"2006","unstructured":"Wei M, Esbaei K, Bargman JM, Oreopoulos DG (2006) Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to a dynamic bone disease? Int Urol Nephrol 38:317\u2013322. doi: 10.1007\/s11255-006-0082-6","journal-title":"Int Urol Nephrol"},{"key":"9510_CR31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/ajkd.2001.25195","volume":"38","author":"M Tamashiro","year":"2001","unstructured":"Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K (2001) Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64\u201369. doi: 10.1053\/ajkd.2001.25195","journal-title":"Am J Kidney Dis"},{"key":"9510_CR32","unstructured":"Spiegel D, Farmer B (2008) Long term effects of magnesium carbonate on vascular calcification and on mineral density in hemodialysis patients\u2014a pilot study. Paper presented at the 14th international symposium on hemodialysis, Orlando, Florida, USA, 2\u20134 March, 2008"},{"issue":"3","key":"9510_CR33","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1523-1755.2004.00875.x","volume":"66","author":"I Kyriazis","year":"2004","unstructured":"Kyriazis I, Kalogeropoulou K, Bilirakis L, Smirniudis N, Pikounis V, Stamatiadis D et al (2004) Dialysate magnesium level and blood pressure. Kidney Int 66(3):1221\u20131231. doi: 10.1111\/j.1523-1755.2004.00875.x","journal-title":"Kidney Int"},{"issue":"Suppl. 2","key":"9510_CR34","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/j.1542-4758.2006.00120.x","volume":"10","author":"MM Elsharkawy","year":"2006","unstructured":"Elsharkawy MM, Youssef AM, Zayoon MY (2006) Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int 10(Suppl. 2):S16\u2013S23. doi: 10.1111\/j.1542-4758.2006.00120.x","journal-title":"Hemodial Int"},{"issue":"Suppl. 2","key":"9510_CR35","first-page":"22","volume":"22","author":"J Kooman","year":"2007","unstructured":"Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D et al (2007) EBPG guideline on hemodynamic instability. Nephrol Dial Transplant 22(Suppl. 2):22\u201344","journal-title":"Nephrol Dial Transplant"},{"key":"9510_CR36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/089686080602600315","volume":"26","author":"M Wei","year":"2006","unstructured":"Wei M, Esbaei K, Bargman J, Oreopoulos DG (2006) Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int 26:366\u2013373","journal-title":"Perit Dial Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9510-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-008-9510-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9510-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T10:10:19Z","timestamp":1589451019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-008-9510-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,30]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["9510"],"URL":"https:\/\/doi.org\/10.1007\/s11255-008-9510-0","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,30]]}}}